Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Transdermal Detection of MB-102 and Correlation to Meropenem Pharmacokinetics During Continuous Renal Replacement Therapy: In Vivo Results.

Autor: Dorshow RB; From the MediBeacon Inc., St. Louis, Missouri., Johnson JR; From the MediBeacon Inc., St. Louis, Missouri., Shieh JJ; From the MediBeacon Inc., St. Louis, Missouri., Riley IR; From the MediBeacon Inc., St. Louis, Missouri., Rogers TE; From the MediBeacon Inc., St. Louis, Missouri., Pino CJ; Innovative BioTherapies, Ann Arbor, Michigan.; Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan., Johnston KA; Innovative BioTherapies, Ann Arbor, Michigan.; Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan., Tang P; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Nolin TD; Department of Pharmacy & Therapeutics, University of Pittsburgh, Pittsburgh, Pennsylvania., Humes HD; Innovative BioTherapies, Ann Arbor, Michigan.; Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan., Goldstein SL; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Publikováno v: ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2023 Jul 01; Vol. 69 (7), pp. 708-715. Date of Electronic Publication: 2023 Jun 27.

Characterization of MB-102, a New Fluorescent Tracer Agent for Point-of-Care Renal Function Monitoring.

Autor: Shieh JJ; MediBeacon Inc., St. Louis, Missouri 63132. Electronic address: rbdorshow@medibeacon.com., Riley IR; MediBeacon Inc., St. Louis, Missouri 63132., Rogers TE; MediBeacon Inc., St. Louis, Missouri 63132., Kao LF; Department of Chemistry, Washington University, St. Louis, Missouri 63130., Dorshow RB; MediBeacon Inc., St. Louis, Missouri 63132.

Publikováno v: Journal of pharmaceutical sciences [J Pharm Sci] 2020 Feb; Vol. 109 (2), pp. 1191-1198. Date of Electronic Publication: 2019 Nov 09.

Resolution of sickle cell disease-associated inflammation and tissue damage with 17 R -resolvin D1.

Autor: Matte A; Department of Medicine, University of Verona, Policlinico GB Rossi-Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy., Recchiuti A; Department of Medical, Oral, and Biotechnology Science and Center of Excellence on Aging and Translational Medicine, 'G. d'Annunzio' University of Chieti, Chieti, Italy., Federti E; Department of Medicine, University of Verona, Policlinico GB Rossi-Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy., Koehl B; Laboratoire d'Excellence GR-Ex, Unité Biologie Intégrée du Globule Rouge, NTS, INSERM, Paris Diderot University, Sorbonne Paris Cité University, Paris, France., Mintz T; Paris Cardiovascular Research Centre, INSERM and Paris Descartes University, Paris, France., El Nemer W; Laboratoire d'Excellence GR-Ex, Unité Biologie Intégrée du Globule Rouge, NTS, INSERM, Paris Diderot University, Sorbonne Paris Cité University, Paris, France., Tharaux PL; Paris Cardiovascular Research Centre, INSERM and Paris Descartes University, Paris, France., Brousse V; Assistance Publique Hopitaux de Paris, Necker Hospital, Paris, France., Andolfo I; Department of Molecular Medicine and Medical Biotechnologies, Federico II University, and CEINGE, Biotecnologie Avanzate, Naples, Italy., Lamolinara A; Center of Excellence on Aging and Translational Medicine, Department of Medicine and Aging Science, 'G. D'Annunzio' University of Chieti, Chieti, Italy., Weinberg O; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA., Siciliano A; Department of Medicine, University of Verona, Policlinico GB Rossi-Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy., Norris PC; Center of Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and., Riley IR; Center of Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and., Iolascon A; Department of Molecular Medicine and Medical Biotechnologies, Federico II University, and CEINGE, Biotecnologie Avanzate, Naples, Italy., Serhan CN; Center of Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and., Brugnara C; Department of Laboratory Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA., De Franceschi L; Department of Medicine, University of Verona, Policlinico GB Rossi-Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.

Publikováno v: Blood [Blood] 2019 Jan 17; Vol. 133 (3), pp. 252-265. Date of Electronic Publication: 2018 Nov 07.

Identification and Actions of the Maresin 1 Metabolome in Infectious Inflammation.

Autor: Colas RA; Department of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Harvard Institutes of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115., Dalli J; Department of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Harvard Institutes of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115., Chiang N; Department of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Harvard Institutes of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115., Vlasakov I; Department of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Harvard Institutes of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115., Sanger JM; Department of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Harvard Institutes of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115., Riley IR; Department of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Harvard Institutes of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115., Serhan CN; Department of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Harvard Institutes of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115 cnserhan@zeus.bwh.harvard.edu.

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2016 Dec 01; Vol. 197 (11), pp. 4444-4452. Date of Electronic Publication: 2016 Oct 31.